Silver Book Fact

Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.

Gin, Thomas J., Chi D. Luu, and Robyn H. Guymer. Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD. Invest Opthalmol Vis Sci. 2011; 52(12): 9267-9274

Reference

Title
Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Gin, Thomas J., Chi D. Luu, and Robyn H. Guymer
Volume & Issue
Volume 52, Issue 12
Pages
9267-9274

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million– in 1994 dollars.  
  • Anti-VEGF Visual Improvement
    Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.  
  • Laser Treatment for DR
    Laser treatment of PDR can reduce the 5-year risk of blindness by 90%, and the risk of visual loss from DME by 50%.  
  • Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens– from an average $623 per early-stage patient to $2,511 per late-stage patient–…  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.